986 related articles for article (PubMed ID: 31001253)
21. The Therapeutic Effect of ICAM-1-Overexpressing Mesenchymal Stem Cells on Acute Graft-Versus-Host Disease.
Tang B; Li X; Liu Y; Chen X; Li X; Chu Y; Zhu H; Liu W; Xu F; Zhou F; Zhang Y
Cell Physiol Biochem; 2018; 46(6):2624-2635. PubMed ID: 29763906
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
Tian Y; Deng YB; Huang YJ; Wang Y
Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
[TBL] [Abstract][Full Text] [Related]
23. Optimization of the therapeutic efficacy of human umbilical cord blood-mesenchymal stromal cells in an NSG mouse xenograft model of graft-versus-host disease.
Jang YK; Kim M; Lee YH; Oh W; Yang YS; Choi SJ
Cytotherapy; 2014 Mar; 16(3):298-308. PubMed ID: 24418403
[TBL] [Abstract][Full Text] [Related]
24. Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease.
Kim KW; Moon SJ; Park MJ; Kim BM; Kim EK; Lee SH; Lee EJ; Chung BH; Yang CW; Cho ML
Stem Cell Res Ther; 2015 Oct; 6():202. PubMed ID: 26497134
[TBL] [Abstract][Full Text] [Related]
25. Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of Treg cells.
Wu R; Liu C; Deng X; Chen L; Hao S; Ma L
J Cell Mol Med; 2020 Jan; 24(2):1684-1699. PubMed ID: 31782262
[TBL] [Abstract][Full Text] [Related]
26. A novel study on the immunomodulatory effect of umbilical cord derived mesenchymal stem cells pretreated with traditional Chinese medicine Asarinin.
He H; Yang T; Li F; Zhang L; Ling X
Int Immunopharmacol; 2021 Nov; 100():108054. PubMed ID: 34492537
[TBL] [Abstract][Full Text] [Related]
27. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
[TBL] [Abstract][Full Text] [Related]
28. The immunosuppressive properties of non-cultured dermal-derived mesenchymal stromal cells and the control of graft-versus-host disease.
Gao L; Liu F; Tan L; Liu T; Chen Z; Shi C
Biomaterials; 2014 Apr; 35(11):3582-8. PubMed ID: 24468404
[TBL] [Abstract][Full Text] [Related]
29. Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood.
Gorin NC; Piantadosi S; Stull M; Bonte H; Wingard JR; Civin C
J Hematother Stem Cell Res; 2002 Apr; 11(2):277-92. PubMed ID: 11983099
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury.
Takahashi A; Nakajima H; Uchida K; Takeura N; Honjoh K; Watanabe S; Kitade M; Kokubo Y; Johnson WEB; Matsumine A
Cell Transplant; 2018 Jul; 27(7):1126-1139. PubMed ID: 29947256
[TBL] [Abstract][Full Text] [Related]
31. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
[TBL] [Abstract][Full Text] [Related]
32. The immunosuppressive signature of menstrual blood mesenchymal stem cells entails opposite effects on experimental arthritis and graft versus host diseases.
Luz-Crawford P; Torres MJ; Noël D; Fernandez A; Toupet K; Alcayaga-Miranda F; Tejedor G; Jorgensen C; Illanes SE; Figueroa FE; Djouad F; Khoury M
Stem Cells; 2016 Feb; 34(2):456-69. PubMed ID: 26528946
[TBL] [Abstract][Full Text] [Related]
33. Mesenchymal stromal cells: a new tool against graft-versus-host disease?
Baron F; Storb R
Biol Blood Marrow Transplant; 2012 Jun; 18(6):822-40. PubMed ID: 21963621
[TBL] [Abstract][Full Text] [Related]
34. Cymerus™ iPSC-MSCs significantly prolong survival in a pre-clinical, humanized mouse model of Graft-vs-host disease.
Ozay EI; Vijayaraghavan J; Gonzalez-Perez G; Shanthalingam S; Sherman HL; Garrigan DT; Chandiran K; Torres JA; Osborne BA; Tew GN; Slukvin II; Macdonald RA; Kelly K; Minter LM
Stem Cell Res; 2019 Mar; 35():101401. PubMed ID: 30738321
[TBL] [Abstract][Full Text] [Related]
35. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease.
Zhao L; Chen S; Yang P; Cao H; Li L
Stem Cell Res Ther; 2019 Jun; 10(1):182. PubMed ID: 31227011
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic efficacy of cord blood-derived mesenchymal stromal cells for the prevention of acute graft-versus-host disease in a xenogenic mouse model.
Gregoire-Gauthier J; Selleri S; Fontaine F; Dieng MM; Patey N; Despars G; Beauséjour CM; Haddad E
Stem Cells Dev; 2012 Jul; 21(10):1616-26. PubMed ID: 21910645
[TBL] [Abstract][Full Text] [Related]
37. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus.
Wang D; Huang S; Yuan X; Liang J; Xu R; Yao G; Feng X; Sun L
Cell Mol Immunol; 2017 May; 14(5):423-431. PubMed ID: 26435067
[TBL] [Abstract][Full Text] [Related]
38. Human umbilical cord mesenchymal stem cells confer potent immunosuppressive effects in Sjögren's syndrome by inducing regulatory T cells.
Liu Y; Li C; Wang S; Guo J; Guo J; Fu J; Ren L; An Y; He J; Li Z
Mod Rheumatol; 2021 Jan; 31(1):186-196. PubMed ID: 31859545
[TBL] [Abstract][Full Text] [Related]
39. Mesenchymal stromal cell supported umbilical cord blood ex vivo expansion enhances regulatory T cells and reduces graft versus host disease.
Fan X; Gay FP; Ong SY; Ang JM; Chu PP; Bari S; Lim TK; Hwang WY
Cytotherapy; 2013 May; 15(5):610-9. PubMed ID: 23419678
[TBL] [Abstract][Full Text] [Related]
40. Adipose tissue-derived human mesenchymal stromal cells can better suppress complement lysis, engraft and inhibit acute graft-versus-host disease in mice.
Wu SCM; Zhu M; Chik SCC; Kwok M; Javed A; Law L; Chan S; Boheler KR; Liu YP; Chan GCF; Poon EN
Stem Cell Res Ther; 2023 Jun; 14(1):167. PubMed ID: 37357314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]